Literature DB >> 34266346

Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors.

Samantha J Montague1, Pushpa Patel2,3, Eleyna M Martin1, Alexandre Slater1, Lourdes Garcia Quintanilla1, Gina Perrella1,4, Caroline Kardeby1, Magdolna Nagy4, Diego Mezzano5, Paula M Mendes2,3, Steve P Watson1,3.   

Abstract

Charge interactions play a critical role in the activation of the innate immune system by damage- and pathogen-associated molecular pattern receptors. The ability of these receptors to recognize a wide spectrum of ligands through a common mechanism is critical in host defense. In this article, we argue that platelet glycoprotein receptors that signal through conserved tyrosine-based motifs function as pattern recognition receptors (PRRs) for charged endogenous and exogenous ligands, including sulfated polysaccharides, charged proteins and nanoparticles. This is exemplified by GPVI, CLEC-2 and PEAR1 which are activated by a wide spectrum of endogenous and exogenous ligands, including diesel exhaust particles, sulfated polysaccharides and charged surfaces. We propose that this mechanism has evolved to drive rapid activation of platelets at sites of injury, but that under some conditions it can drive occlusive thrombosis, for example, when blood comes into contact with infectious agents or toxins. In this Opinion Article, we discuss mechanisms behind charge-mediated platelet activation and opportunities for designing nanoparticles and related agents such as dendrimers as novel antithrombotics.

Entities:  

Keywords:  CLEC-2; GPVI; nanoparticles; pattern recognition receptors; PEAR1; platelets

Mesh:

Substances:

Year:  2021        PMID: 34266346     DOI: 10.1080/09537104.2021.1945571

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  2 in total

1.  Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear.

Authors:  Gina Perrella; Samantha J Montague; Helena C Brown; Lourdes Garcia Quintanilla; Alexandre Slater; David Stegner; Mark Thomas; Johan W M Heemskerk; Steve P Watson
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

2.  Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist.

Authors:  Luis A Morán; Ying Di; Marcin A Sowa; Lidia Hermida-Nogueira; María N Barrachina; Eleyna Martin; Joanne C Clark; Todd H Mize; Johannes A Eble; David Moreira; Alice Y Pollitt; María I Loza; Eduardo Domínguez; Steve P Watson; Ángel García
Journal:  Thromb Haemost       Date:  2022-02-15       Impact factor: 6.681

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.